Please login to the form below

Not currently logged in
Email:
Password:

Orphacol

This page shows the latest Orphacol news and features for those working in and with pharma, biotech and healthcare.

EC sets up expert group on rare diseases

EC sets up expert group on rare diseases

approve a previously-rejected drug - CTRS' Orphacol - earlier this month.

Latest news

  • Court orders EC to approve rejected orphan medicine Court orders EC to approve rejected orphan medicine

    Says CTRS should be allowed to market Orphacol for the treatment of rare bile condition. ... The battle pitched small French pharma company Cell Therapies Research &Services (CTRS) against the Commission and focused on Orphacol (cholic acid), a drug

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Say Communications

Influencing positive behaviours and delivering change is what drives us, using thought leadership, education, social and professional engagement and compelling,...

Latest intelligence

London
“Brexit has been a catalyst for UK clinical research... it’s turbocharged change”
The UK clinical trials environment has been transformed in recent years – but can it really buck Brexit’s risks and uncertainties?...
The Future of Pharma sales: fast forward to 2029
Change is inevitable, and necessary, for growth in business....
International Women's Day - 8 March 2019
International Women's Day has been celebrated since its inception in 1911. But how far have we come?...

Infographics